Search results
1 company and 5 research reports found for "Photocure"
Company results
- Photocure
Photocure specialises in photodynamic therapy. It has an approved imaging product, Hexvix, sold by G...
Sector reports
No sector reports have been found.
Research results
Photocure
Building a US operation
QuickView | Pharmaceutical & Healthcare | 22/02/2012FY11 results showed sales and royalties of NOK82.9m. Milestones on the Ipsen European Hexvix (bladder cancer imaging) marketing deal added NOK32.7m ma...
Photocure
Key transitional year
QuickView | Pharmaceutical & Healthcare | 16/01/2012In H211, Photocure implemented a new commercial strategy for its bladder cancer imaging agent Hexvix/Cysview, transforming the potential of its busine...
Photocure
Norwegian blue in US
QuickView | Pharmaceutical & Healthcare | 29/09/2011Photocure has regained its bladder cancer in situ diagnostic imaging agent Hexvix from GE Healthcare. Directly selling Hexvix in the US will transform...
Photocure
A rosy glow in the US
QuickView | Pharmaceutical & Healthcare | 22/06/2011Photocure has launched its direct sales operation for Allumera, a new cosmetic skin rejuvenation treatment offering pore size reduction for a smoother...
Photocure
Vibrations of success
QuickView | Pharmaceutical & Healthcare | 27/01/2011Positive Phase IIa results for novel vaginal photodynamic therapy drug/device, Cevira, in the treatment of pre-cancerous cervical lesions, opens a new...
